A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party (Q35984775)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party (English)

1 reference

Europe PubMed Central

11 August 2017

group psychotherapy

1 reference

based on heuristic

inferred from title

author name string

Hayward RL

1

1 reference

Europe PubMed Central

11 August 2017

Leonard RC

2

1 reference

Europe PubMed Central

11 August 2017

Prescott RJ

3

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 June 1991

1 reference

Europe PubMed Central

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

11 August 2017

63

1 reference

Europe PubMed Central

11 August 2017

945-952

1 reference

Europe PubMed Central

11 August 2017

6

1 reference

Europe PubMed Central

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1991.207

0 references

Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Current status and perspectives in the treatment of non-Hodgkin's lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Interpretation of clinical trials in diffuse large-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Malignant lymphomas of follicular center cell origin in man.III. Prognostic Features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

Advanced diffuse histiocytic lymphoma, a potentially curable disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

2 October 2017

A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

11 July 2018

Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1972546

11 July 2018

Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent trends in the treatment of non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM Regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of immunologic phenotype in diffuse large cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive model for prognosis in advanced diffuse histiocytic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2069849

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1991.207

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35984775&oldid=1610083417"